These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 17050806

  • 1. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status.
    Ory B, Blanchard F, Battaglia S, Gouin F, Rédini F, Heymann D.
    Mol Pharmacol; 2007 Jan; 71(1):333-43. PubMed ID: 17050806
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 5. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G.
    Lee JH, Jeong YJ, Lee SW, Kim D, Oh SJ, Lim HS, Oh HK, Kim SH, Kim WJ, Jung JY.
    Cancer Lett; 2010 Apr 01; 290(1):68-75. PubMed ID: 19781850
    [Abstract] [Full Text] [Related]

  • 6. The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis.
    Sewing L, Steinberg F, Schmidt H, Göke R.
    Apoptosis; 2008 Jun 01; 13(6):782-9. PubMed ID: 18437576
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
    Tamura T, Shomori K, Nakabayashi M, Fujii N, Ryoke K, Ito H.
    Oncol Rep; 2011 Apr 01; 25(4):1139-43. PubMed ID: 21249320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined effects of bisphosphonate and radiation on osteosarcoma cells.
    Ryu K, Murata H, Koto K, Horie N, Matsui T, Nishigaki Y, Sakabe T, Takeshita H, Itoi M, Kimura S, Ashihara E, Maekawa T, Fushiki S, Kubo T.
    Anticancer Res; 2010 Jul 01; 30(7):2713-20. PubMed ID: 20683003
    [Abstract] [Full Text] [Related]

  • 12. Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.
    Okamoto S, Kawamura K, Li Q, Yamanaka M, Yang S, Fukamachi T, Tada Y, Tatsumi K, Shimada H, Hiroshima K, Kobayashi H, Tagawa M.
    J Thorac Oncol; 2012 May 01; 7(5):873-82. PubMed ID: 22481236
    [Abstract] [Full Text] [Related]

  • 13. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H, Sohara Y, Moats RA, Nelson MD, Groshen SG, Ye W, Reynolds CP, DeClerck YA.
    Cancer Res; 2007 Oct 01; 67(19):9346-55. PubMed ID: 17909043
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells.
    Rudolf E, Rudolf K, Cervinka M.
    Cell Biol Toxicol; 2008 Apr 01; 24(2):123-41. PubMed ID: 17610029
    [Abstract] [Full Text] [Related]

  • 17. Regulation of AIF expression by p53.
    Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V.
    Cell Death Differ; 2006 Dec 01; 13(12):2140-9. PubMed ID: 16729031
    [Abstract] [Full Text] [Related]

  • 18. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R, Sourla A, Lembessis P, Koutsilieris M.
    Anticancer Res; 2006 Dec 01; 26(1A):283-91. PubMed ID: 16475708
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.
    Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F, Yang Q, Gao G, Gong Y, Shao C.
    Mutat Res; 2009 Mar 09; 662(1-2):75-83. PubMed ID: 19159633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.